Press "Enter" to skip to content

Posts tagged as “UroToday”

Prostate-Specific Membrane Antigen Ligand Positron-Emission Tomography in Men with Nonmetastatic Castration-Resistant Prostate Cancer – Beyond the Abstract – UroToday

admin 0

Prostate-Specific Membrane Antigen Ligand Positron-Emission Tomography in Men with Nonmetastatic Castration-Resistant Prostate Cancer – Beyond the Abstract  UroToday “prostate cancer” – Google News

Prostate Cancer Risk Stratification in Men With a Clinical Suspicion of Prostate Cancer Using a Unique Biparametric MRI and Expression of 11 Genes in Apparently Benign Tissue: Evaluation Using Machine-Learning Techniques. – UroToday

admin 0

Prostate Cancer Risk Stratification in Men With a Clinical Suspicion of Prostate Cancer Using a Unique Biparametric MRI and Expression of 11 Genes in Apparently Benign Tissue: Evaluation Using Machine-Learning…

The role of radical prostatectomy and definitive external beam radiotherapy in combined treatment for high-risk prostate cancer: a systematic review and meta-analysis. – UroToday

admin 0

The role of radical prostatectomy and definitive external beam radiotherapy in combined treatment for high-risk prostate cancer: a systematic review and meta-analysis.  UroToday “prostate cancer” – Google News

Tumor-Associated Release of Prostatic Cells into the Blood after Transrectal Ultrasound-Guided Biopsy in Patients with Histologically Confirmed Prostate Cancer. – UroToday

admin 0

Tumor-Associated Release of Prostatic Cells into the Blood after Transrectal Ultrasound-Guided Biopsy in Patients with Histologically Confirmed Prostate Cancer.  UroToday “prostate cancer” – Google News

SIU 2019: The Impact of Positive Surgical Margins, Biochemical Recurrence or PSA Persistence on Oncological Outcomes After Radical Prostatectomy – UroToday

admin 0

SIU 2019: The Impact of Positive Surgical Margins, Biochemical Recurrence or PSA Persistence on Oncological Outcomes After Radical Prostatectomy  UroToday “prostate cancer” – Google News

Ultra-Hypofractionated Radiation Therapy for Unfavorable Intermediate-Risk and High-Risk Prostate Cancer is Safe and Effective: 5-year Outcomes of a Phase II Trial. – UroToday

admin 0

Ultra-Hypofractionated Radiation Therapy for Unfavorable Intermediate-Risk and High-Risk Prostate Cancer is Safe and Effective: 5-year Outcomes of a Phase II Trial.  UroToday “prostate cancer” – Google News